CSS
NXTC icon

Cubist Systematic Strategies’s NextCure NXTC Stock Holding History

Cubist Systematic Strategies’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,014
Closed -$33K – 4495
2022
Q3 		$33K Buy
+1,014
New +$51.7K ﹤0.01% 4182
2022
Q1 		– Sell
-1,532
Closed -$110K – 3710
2021
Q4 		$110K Buy
1,532
+333
+28% +$27.9K ﹤0.01% 3181
2021
Q3 		$97K Sell
1,199
-851
-42% -$74.6K ﹤0.01% 2750
2021
Q2 		$198K Buy
2,050
+626
+44% +$64.1K ﹤0.01% 2568
2021
Q1 		$171K Sell
1,424
-558
-28% -$80.8K ﹤0.01% 2524
2020
Q4 		$259K Sell
1,982
-2,290
-54% -$296K ﹤0.01% 2112
2020
Q3 		$451K Buy
4,272
+2,731
+177% +$336K 0.01% 1810
2020
Q2 		$396K Buy
+1,541
New +$587K 0.01% 1708

Other funds holding NXTC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Cubist Systematic Strategies's NXTC Position: Q4 2022 in Review

Cubist Systematic Strategies sold out of NextCure (NXTC) in Q4 2022, closing a stake of 1,014 shares — an estimated $33K sold.

Cubist Systematic Strategies first reported a position in NXTC in Q2 2020 and held it in 8 quarters. The position peaked at $451K in Q3 2020. 45 funds tracked by Wall St. Rank hold NXTC as of Q4 2022.

  • Cubist Systematic Strategies reported no remaining NextCure position as of Q4 2022 after selling out during the quarter.
  • Cubist Systematic Strategies sold 1,014 NextCure shares in Q4 2022, an estimated $33K.
  • Cubist Systematic Strategies first reported a position in NextCure in Q2 2020 and held it in 8 quarters.
  • Cubist Systematic Strategies's NextCure position peaked at $451K in Q3 2020.
  • 45 funds tracked by Wall St. Rank held NextCure as of Q4 2022.

Based on Cubist Systematic Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.